Austerity measures could further shrink French drug market

03/20/2013 | Chicago Tribune (tiered subscription model)

Drug sales in France, Europe's second largest market, are expected to decline more than 3% this year as the government continues to reduce health care spending through price cuts and greater use of generics, according to the pharmaceutical intelligence firm IMS Health. By contrast, other mature markets like the United States, Germany and Japan should register slight increases, and growth rates in Brazil and China may exceed 10%. This is the second consecutive year of declines in France.

View Full Article in:

Chicago Tribune (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
MN
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC